Skip to main content
OpenTrials

Clinical trial condition

Histiocytic Disorders, Malignant

Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.

271 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Histiocytic Disorders, Malignant trial results

Recruiting

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

NCT06220032

Conditions
Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +22 more
Locations
  • NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
  • NL-Almelo-ZGTALMELO Almelo, Netherlands
  • NL-Amstelveen-AMSTELLAND Amstelveen, Netherlands
  • NL-Apeldoorn-GELREAPELDOORN Apeldoorn, Netherlands
View all 25 locations
View Trial Details
Recruiting

A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy

NCT07785180

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Odense University Hospital Odense, Denmark
  • Centre Hospitalier Universitaire Besancon Besançon, France
  • Hôpital Avicenne Bobigny, France
View all 67 locations
View Trial Details
Recruiting

A Registry-study of ELZONRIS in Participants With BPDCN

NCT07785154

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Medical University Innsbruck Innsbruck, Austria
  • Ordensklinikum Linz Krankenhaus der Elisabethinen Linz Linz, Austria
  • Salzburg Cancer Research Institute (SCRI) Salzburg, Austria
  • Medizinische Universitat Wien, Department for Internal Medicine I, Division of Hematology and Haemostaseology Vienna, Austria
View all 41 locations
View Trial Details
Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
  • IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
  • Hospital Beata Maria Ana Madrid, Spain
  • Hospital Fundación Jiménez Diaz Madrid, Spain
View all 17 locations
View Trial Details

Related conditions